1 enrolling by invitation, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Enrolling by invitation 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow GI Cancers: new trials by email Literature Review of GI Cancers trials Research Report on GI Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-in-human Study of 7MW4911 in GI Cancer 7MW4911 - GI Cancers | Phase 1 / Phase 2 | Recruiting | Mabwell (Shanghai) Bioscience Co., Ltd. | 200 | 2026-01-13 | 2026-11-02 |
| Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies oxaliplatin, Fluoropyrimidine - GI Cancers | Phase 2 | Enrolling by invitation | University of Vermont Medical Center | 20 | 2024-10-21 | 2026-02-05 |
Oxaliplatin (1)
Mabwell (Shanghai) Bioscience Co., Ltd. (1) · University of Vermont Medical Center (1)
United States (2)